Concepedia

The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn’s disease

Hiroyuki Tamaki, Hiroshi Nakase, Minoru Matsuura, Satoko Inoue, Sakae Mikami, Satoru Ueno, Norimitsu Uza, Hiroshi Kitamura, Katsuhiro Kasahara, Tsutomu Chiba

Journal of Gastroenterology · 2008 · 29 citations · 24 references

DOI

Concepts

References

24

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Richard F. Harvey, J.M. Bradshaw · The Lancet · 1980 · 3K citations

, , +12

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Toru Kino, Hiroshi Hatanaka, Susumu Miyata et al. · The Journal of Antibiotics · 1987 · 1.2K citations · Full text

, , +9

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Michael J. Tocci, D A Matkovich, Kathy Collier et al. · The Journal of Immunology · 1989 · 670 citations

, , +16

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

Hisao Ogata · Gut · 2006 · 462 citations · Full text

, , +14

Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial

William J. Sandborn, Daniel H. Present, Kim L. Isaacs et al. · Gastroenterology · 2003 · 334 citations · Full text

, , +11